NHU Projects Profit Surge of Up to 70 Percent in H1 2025 Reaching 37.5 Billion Yuan
On July 1, 2025, NHU (Zhejiang NHU Co., Ltd.) released its 2025 interim earnings forecast, expecting net profit attributable to shareholders to hit 33 billion to 37.5 billion yuan, marking a 50%-70% year-on-year growth. For Q2 alone, NHU anticipates net profit of 14.2 billion to 18.7 billion yuan.
This profit surge is largely driven by the nutrition products segment, where increased sales volumes and higher prices for key products boosted performance. NHU has maintained strong profit momentum from 2024, when its annual revenue reached 216.1 billion yuan, up 42.95%, and net profit grew 117.01% to 58.69 billion yuan.
NHU operates across four core business areas:
-
Nutrition Products: The company produces a wide range of vitamins (E, A, D3, B12, etc.), amino acids (methionine, serine, cystine), and coenzymes like Q10. These are used in feed additives, food supplements, and health products. Significant advancements include achieving 30 million tons/year capacity, nearing completion of a 180,000 tons/year methionine project, and stable operation of the cystine production line.
-
Fragrances and Flavors: NHU specializes in producing ingredients such as citral, linalool, and menthol, widely used in personal care and food industries. Ongoing projects include the fragrance industrial park Phase I and the SA aldehyde series project.
-
High-Performance Polymers: NHU focuses on PPS, PPA, HDI, and other materials for automotive, electronics, and environmental applications. Key achievements include the start of a nylon materials project in Tianjin and the first phase of the IPDI project reaching production.
-
Pharmaceutical APIs: NHU produces vitamins, antibiotics, and intermediates for active pharmaceutical ingredients (APIs), including moxifloxacin HCl and vitamin A.
NHU’s strategic investments in R&D and capacity expansion have positioned it for sustained growth across multiple industries, from nutrition and healthcare to new energy vehicles and industrial applications.
2026-10-25
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
WACKER’s 2025 Loss Reaches €805 Million as the PACE Cost-Cutting Plan Becomes the Key Variable for 2026
-
India Proposes New GMP Rules for Clinical Trial and API Manufacturing
-
The End of Hype: Europe’s Bio-stimulant Industry Faces a Science-First Reckoning by 2030
-
Japan Tightens the Rules—Then Loosens Them: A Surprising Shift in Food Additive Policy
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
2026 Q1 Chemical Giant Earnings: Supply Contraction, Flat Demand, Full-Scale "Defense Priority"
-
U.S. Finds Methionine Dumping Could Recur, With Japan Margin Up to 76.50%
-
U.S. Finds Chinese Potassium Phosphate Dumping Could Recur at Margins Up to 95.40%
-
U.S. Finds Methionine Dumping Could Recur, With Japan Margin Up to 76.50%
-
EU PIC Amendment Adds Over 30 Chemicals to Control List and Bans 3 POPs Exports
Recommend Reading
-
Colombia Makes Preliminary Ruling in Anti-Dumping Investigation into Chinese DOP Imports
-
FDA Color Policy Uncertainty Opens a New Chapter for Food Ingredient Reform
-
FDA Tracks Industry Dye Removal
-
India Prepares New Seed and Pesticide Laws
-
Syngenta Caught in Trade Crossfire
-
Business Society’s Market Outlook for Phthalic Anhydride on August 18, 2026: Maintaining Volatility
-
In April, the Chinese ammonium sulfate market showed mixed trends
-
Business Society’s Market Outlook for China’s Hydrofluoric Acid on August 18, 2026: Price Trend Is Volatile
-
Business Society October 12, 2026 MTBE Trend Analysis: Strong Consolidation
-
Heptane: Properties, Uses, and Industrial Applications